RAPGEF4
Basic information
Region (hg38): 2:172735274-173052893
Links
Phenotypes
GenCC
Source:
- prostate cancer (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAPGEF4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 43 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 5 | 6 |
Variants in RAPGEF4
This is a list of pathogenic ClinVar variants found in the RAPGEF4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-172736006-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
2-172795080-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
2-172795130-A-G | Likely benign (Jun 06, 2018) | |||
2-172797542-A-G | not specified | Uncertain significance (May 05, 2023) | ||
2-172814348-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
2-172814354-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
2-172814390-C-T | not specified | Uncertain significance (May 20, 2024) | ||
2-172814393-A-G | not specified | Uncertain significance (Jul 15, 2021) | ||
2-172917824-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
2-172961128-T-A | not specified | Uncertain significance (Jun 05, 2023) | ||
2-172961162-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
2-172961223-A-G | Benign (Apr 25, 2018) | |||
2-172967270-A-C | not specified | Uncertain significance (Dec 19, 2023) | ||
2-172967317-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
2-172967323-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
2-172967362-T-C | Benign (Apr 25, 2018) | |||
2-172983551-A-G | not specified | Uncertain significance (Sep 27, 2021) | ||
2-172985490-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
2-172988220-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
2-172988774-G-A | not specified | Uncertain significance (Aug 02, 2023) | ||
2-172990813-G-C | not specified | Uncertain significance (Jun 18, 2021) | ||
2-172990883-G-A | not specified | Uncertain significance (Mar 29, 2024) | ||
2-172996518-A-G | not specified | Uncertain significance (Aug 30, 2021) | ||
2-172996521-A-G | Benign (Jun 06, 2018) | |||
2-172996524-C-T | not specified | Uncertain significance (Jan 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RAPGEF4 | protein_coding | protein_coding | ENST00000397081 | 31 | 317620 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.992 | 0.00782 | 124762 | 0 | 34 | 124796 | 0.000136 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 447 | 570 | 0.784 | 0.0000318 | 6629 |
Missense in Polyphen | 165 | 231.91 | 0.71149 | 2686 | ||
Synonymous | 0.358 | 200 | 207 | 0.968 | 0.0000118 | 1894 |
Loss of Function | 6.25 | 12 | 67.4 | 0.178 | 0.00000397 | 746 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000187 | 0.000187 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000279 | 0.000278 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.000279 | 0.000278 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Guanine nucleotide exchange factor (GEF) for RAP1A, RAP1B and RAP2A small GTPases that is activated by binding cAMP. Seems not to activate RAB3A. Involved in cAMP-dependent, PKA- independent exocytosis through interaction with RIMS2 (By similarity). {ECO:0000250, ECO:0000269|PubMed:10777494, ECO:0000269|PubMed:9856955}.;
- Pathway
- Adrenergic signaling in cardiomyocytes - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Insulin secretion - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Signal Transduction;Integrin alphaIIb beta3 signaling;Immune System;Metabolism;Rap1 signalling;Adaptive Immune System;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion;GPCR signaling-G alpha s Epac and ERK;Platelet Aggregation (Plug Formation);Platelet activation, signaling and aggregation;GPCR signaling-G alpha s PKA and ERK;Integrin signaling;Hemostasis;Integration of energy metabolism
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.583
- rvis_EVS
- -0.77
- rvis_percentile_EVS
- 13.15
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- Y
- hipred_score
- 0.680
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.844
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rapgef4
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;small GTPase mediated signal transduction;calcium ion regulated exocytosis;regulation of exocytosis;cAMP-mediated signaling;insulin secretion;regulation of insulin secretion;regulation of synaptic vesicle cycle
- Cellular component
- cytosol;plasma membrane;membrane;hippocampal mossy fiber to CA3 synapse
- Molecular function
- guanyl-nucleotide exchange factor activity;Ras guanyl-nucleotide exchange factor activity;protein binding;Ras GTPase binding;cAMP binding